Study of EPI-003 for chronic hepatitis B
Part of Digestive system, Infections clinical trials.
This trial tests an experimental medicine called EPI-003 for people with chronic hepatitis B. It aims to see if the drug can help control the virus better and maybe lead to a functional cure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have had chronic hepatitis B for at least 6 months.
- You have been on a stable dose of your hepatitis B medication (entecavir, tenofovir, or tenofovir alafenamide) for at least 6 months.
- Your hepatitis B viral levels have been very low or undetectable for at least 6 months.
- You do not have advanced liver scarring (cirrhosis) or other significant liver disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental injection called EPI-003 for chronic hepatitis B, which aims to help control the virus. You must already be on a stable hepatitis B medication to join.
This study tests a new drug, GST-HG131, for people with chronic hepatitis B who are already on stable treatment. It aims to see if the drug is safe and reduces the virus further.
This trial tests a new injection called AHB-137 for people with chronic hepatitis B. It aims to see if the drug is safe and helps control the virus.
This trial tests a new treatment (GST-HG131&141 tablets) versus a placebo for people with chronic hepatitis B. It aims to see if the treatment can better control the virus in those already on stable therapy.
This trial tests a new drug called GST-HG141 for people with chronic hepatitis B whose virus is still active despite taking standard antiviral pills. It aims to see if the new drug can better control the virus.
This study tests a new drug called HH-006 to see if it can help treat chronic hepatitis B infection. Participants will be grouped by their infection level, and the study checks whether the drug is safe and works to reduce the hepatitis B virus.
Hear when a new Chronic Hepatitis B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.